The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Merck
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech/Roche; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); IION Foundation (Inst)
Estimating long-term survival of PD-L1-expressing, previously treated, non-small cell lung cancer patients who received pembrolizumab in KEYNOTE-001 and -010.
 
Matthew David Hellmann
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Inovio Pharmaceuticals; Merck; Third Rock Ventures
Research Funding - Bristol-Myers Squibb; Genentech/Roche
 
Junshui Ma
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Rina Hui
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD; Novartis
 
Leena Gandhi
No Relationships to Disclose
 
Jean-Charles Soria
Honoraria - Merck
 
Keaven M. Anderson
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Gregory M. Lubiniecki
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Bilal Piperdi
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Roy S. Herbst
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; NovaRX; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Endocyte; Kolltan Pharmaceuticals
Research Funding - Genentech/Roche